Benchmark Reiterates Buy on NVIDIA, $335 Price Target

Aug 21, 2026 Analyst: Cody Acree 1 min read Reproduced verbatim Published as The Benchmark Company, now part of StoneX
Rating
Buy
Price target
$335
Implied upside
+54%
vs $216.85 prior close
StoneX and NVIDIA logos

Benchmark analyst Cody Acree reiterated a Buy rating and $335 price target on NVIDIA (NASDAQ: NVDA) on August 21, 2026.

“NVIDIA reports fiscal 2Q27 after the close on Wednesday, August 26.

Our revised $92.000B/$2.10 July forecast is $1.000B/$0.02 above our prior estimate and compares with updated Street at $92.039B/$2.09.

We raise fiscal 3Q27 to $103.957B/$2.37 from $101.747B/$2.31, essentially matching updated consensus at $104.031B/$2.36.

The increases reflect positive intra-quarter company commentary, broad AI peer and customer capex signals, and a conservative early China contribution.

The October guide, the first Vera Rubin system standups and the gross-margin bridge should still matter more than a modest July variance.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Tracking this call

Since this note+10% NVDA $216.85 → $239.41 (Oct 6) · 19% of the way to the target

This callScored on Feb 20, 2027, six months after the note: did NVDA reach $335?

Firm track recordStoneX reached 50% of its 12 scored targets within six months (#27 of 31 firms); on NVIDIA, 0 of 2. Accuracy ranking →

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.